Lavitra Pharmaceutical Private Limited
About Lavitra Pharmaceutical Private Limited
Data last updated:
Lavitra Pharmaceutical Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It operates in the business support services segment of the business services sector. It was incorporated on 19 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85300UP2016PTC087181.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pratima Singh and Ram Murti Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S 1/121 – R – H Gilat Bazar Sikaraul, Varanasi, Uttar Pradesh, India – 221002.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lavitra Pharmaceutical Private Limited's registered office is in Varanasi, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressS 1/121 – R – H Gilat Bazar Sikaraul, Varanasi, Uttar Pradesh, India – 221002
- IndustryBusiness Services, Business Support Services
To see the full contact details of Lavitra Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lavitra Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lavitra Pharmaceutical Private Limited, buy the company report.
Financials of Lavitra Pharmaceutical Private Limited
FY 2025 filings availableLavitra Pharmaceutical Private Limited reported revenue of ₹239 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 87% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lavitra Pharmaceutical Private Limited, buy the company report.
Board of directors of Lavitra Pharmaceutical Private Limited
Lavitra Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pratima Singh | Director | 19 Oct 2016 | 10 Years 0 Months | Current |
| Ram Murti Singh Also directs: Trimurti Cardiac Care Centre Private Limited | Director | 19 Oct 2016 | 10 Years 0 Months | Current |
Auditor
Lavitra Pharmaceutical Private Limited is audited by S BAJAJ & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S BAJAJ & CO | FY 2019 | 017857C |
Shareholding
The shareholding of Lavitra Pharmaceutical Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Lavitra Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lavitra Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lavitra Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Lavitra Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Lavitra Pharmaceutical Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Pratima Singh was appointed as Director on 19 Oct 2016.
Frequently asked questions
Lavitra Pharmaceutical is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in business support services, within the business services industry. It was incorporated on 19 October 2016 (10+ years old) and is registered under CIN U85300UP2016PTC087181.
Lavitra Pharmaceutical has 2 current directors:
- Pratima Singh - Director
- Ram Murti Singh - Director
The latest financial statements of Lavitra Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Lavitra Pharmaceutical is U85300UP2016PTC087181. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lavitra Pharmaceutical was incorporated on 19 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Pratima Singh was appointed as Director on 19 Oct 2016. Ram Murti Singh was appointed as Director on 19 Oct 2016.
The registered office of Lavitra Pharmaceutical is at S 1121 – R – H Gilat Bazar Sikaraul, Varanasi, Uttar Pradesh, India – 221002.
Lavitra Pharmaceutical operates in the business services industry, in the business support services segment.
The compliance status of Lavitra Pharmaceutical is compliant as of 21 September 2026. The company is actively filing with the Registrar of Companies.
Lavitra Pharmaceutical can be reached at its registered office: S 1121 – R – H Gilat Bazar Sikaraul, Varanasi, Uttar Pradesh, India – 221002.